A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT02471846 · COMPLETED
Trial details
- NCT number
- NCT02471846
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-28
- Primary completion
- 2019-10-02
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.